Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
86 Leser
Artikel bewerten:
(0)

Research and Markets - Global Cosmetic Surgery Market 2016-2020 - Key Vendors are Allergan, Cynosure, Merz Pharma, Galderma & Valeant Pharmaceuticals

DUBLIN, October 26, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Cosmetic Surgery Market 2016-2020" report to their offering.

The global cosmetic surgery market to grow at a CAGR of 6.80% during the period 2016-2020.

The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The report covers the present scenario and the growth prospects of the global cosmetic surgery market for 2016-2020. To calculate the market size, the report considers the revenue generated from the execution of the different types of cosmetic surgeries.

Rise in medical tourism will be a key trend for market growth. Top medical tourism destinations are Thailand, Hungary, India, Singapore, Malaysia, Philippines, US, Costa Rica, Brazil, Mexico south Korea, Columbia, Belgium, Panama, Israel, Turkey, and Taiwan.

According to the report, increased cases of obesity worldwide will be a key driver for market growth. In a report published by the World Health Organization (WHO), the total number of cases related to obesity has doubled since 1980. This is an alarming trend as obesity causes many diseases such as cardiac disease and stroke, diabetes, high blood pressure, cancers, osteoarthritis, gout, gallbladder disease and gallstones, and breathing problems.

Further, the report states that the increase in government regulations will be a challenge for the market. Government regulations related to cosmetic surgery have grown in the past years, triggered by an increase in number of complaints. In the last decade, the FDA has received more than 930 reports of adverse effects of approved dermal facial fillers. There have been many reports of severe and unexpected problems in people who were treated with facial dermal fillers. According to the US FDA, cosmetic surgery products are required to carry detailed warning labels about possible adverse effects.

Key vendors

  • Allergan
  • Cynosure
  • Merz Pharma
  • Galderma
  • Valeant Pharmaceuticals

Other prominent vendors

  • Alma Lasers
  • AQTIS Medical
  • AART
  • Andrew Technologies
  • BTL Industries
  • Cutera
  • ColBar LifeScience
  • Erchonia
  • Genesis Biosystems
  • HCBeauty
  • Hangzhou Techderm Biological Products
  • Human med
  • InMode
  • Invasix Aesthetic Solutions
  • Laboratory Obvieline
  • Lumenis
  • Medytox
  • Mentor Worldwide
  • Polymekon
  • Qufu GuangIng Biochem
  • Revitacare
  • Suneva Medical
  • SciVision Biotech
  • Speciality European Pharma
  • Sciton
  • Syneron Medical
  • VCA Laser
  • Visionmed
  • Wells Johnson Company
  • YOLO Medical
  • ZELTIQ Aesthetics

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Product segmentation

Part 07: Geographical segmentation

Part 08: Market drivers

Part 09: Impact of drivers

Part 10: Market challenges

Part 11: Impact of drivers and challenges

Part 12: Market trends

Part 13: Vendor landscape

Part 14: Key vendor analysis

Part 15: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/3s8jh9/global_cosmetic

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.